ONKURE THERAPEUTICS, INC. Capital Expenditures
ONKURE THERAPEUTICS, INC. (OKUR) reported Capital Expenditures of $8.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-04
- ONKURE THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $3.00K, a 76.92% decline year-over-year.
- ONKURE THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $5.00K, a 72.22% decline year-over-year.
- ONKURE THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $9.00K, a 40.00% decline year-over-year.
- ONKURE THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $6.00K, a 66.67% decline year-over-year.
- ONKURE THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $46.00K, a 11.54% decline from fiscal 2024.
- ONKURE THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $52.00K, a 78.86% decline from fiscal 2023.
- ONKURE THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $246.00K, a 28.90% decline from fiscal 2022.
- ONKURE THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $346.00K, a 74.75% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $8.00K 10-Q · filed 2026-08-04 | $17.00K derived: sum of 3 quarters · filed 2026-08-04 | $23.00K derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2026-03-31 | $5.00K 10-Q · filed 2026-05-05 | $14.00K derived: sum of 2 quarters · filed 2026-05-05 | $20.00K derived: sum of 3 quarters · filed 2026-05-05 | $33.00K derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $15.00K derived: sum of 2 quarters · filed 2026-03-12 | $28.00K derived: sum of 3 quarters · filed 2026-08-04 | $46.00K 10-K · filed 2026-03-12 | |||
| 2025-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $19.00K derived: sum of 2 quarters · filed 2026-08-04 | $37.00K 10-Q · filed 2025-11-06 | $52.00K derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $31.00K 10-Q · filed 2026-08-04 | $46.00K derived: sum of 3 quarters · filed 2026-08-04 | $64.00K derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-03-31 | $18.00K 10-Q · filed 2026-05-05 | $33.00K derived: sum of 2 quarters · filed 2026-05-05 | $51.00K derived: sum of 3 quarters · filed 2026-05-05 | $61.00K derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $33.00K derived: sum of 2 quarters · filed 2026-03-12 | $43.00K derived: sum of 3 quarters · filed 2026-03-12 | $52.00K 10-K · filed 2026-03-12 | |||
| 2024-09-30 | $18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $28.00K derived: sum of 2 quarters · filed 2025-11-06 | $37.00K 10-Q · filed 2025-11-06 | $2.00K 10-Q · filed 2024-11-07 | $87.00K derived: sum of 4 quarters · filed 2025-11-06 | ||
| 2024-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $19.00K 10-Q · filed 2025-08-12 | $2.00K 10-Q · filed 2024-08-13 | $69.00K derived: sum of 3 quarters · filed 2025-08-12 | $88.00K derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | $9.00K 10-Q · filed 2025-05-06 | $59.00K derived: sum of 2 quarters · filed 2025-05-06 | $78.00K derived: sum of 3 quarters · filed 2025-05-06 | $83.00K derived: sum of 4 quarters · filed 2025-05-06 | |||
| 2023-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $69.00K derived: sum of 2 quarters · filed 2025-03-10 | $74.00K derived: sum of 3 quarters · filed 2025-03-10 | $246.00K 10-K · filed 2025-03-10 | $221.00K 10-K · filed 2024-03-28 | ||
| 2023-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $24.00K derived: sum of 2 quarters · filed 2024-11-07 | $196.00K 10-Q · filed 2024-11-07 | $446.00K derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $177.00K 10-Q · filed 2024-08-13 | $427.00K derived: sum of 3 quarters · filed 2024-08-13 | $455.00K derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | $172.00K 10-Q · filed 2024-05-07 | $422.00K derived: sum of 2 quarters · filed 2024-05-07 | $450.00K derived: sum of 3 quarters · filed 2024-05-07 | $474.00K derived: sum of 4 quarters · filed 2024-05-07 | |||
| 2022-12-31 | $250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $278.00K derived: sum of 2 quarters · filed 2024-03-28 | $302.00K derived: sum of 3 quarters · filed 2024-03-28 | $346.00K 10-K · filed 2024-03-28 | |||
| 2022-09-30 | $28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $52.00K derived: sum of 2 quarters · filed 2023-11-13 | $96.00K 10-Q · filed 2023-11-13 | $186.00K derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $68.00K 10-Q · filed 2023-08-10 | $158.00K derived: sum of 3 quarters · filed 2023-08-10 | $235.00K derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | $44.00K 10-Q · filed 2023-05-11 | $134.00K derived: sum of 2 quarters · filed 2023-05-11 | $211.00K derived: sum of 3 quarters · filed 2023-05-11 | $217.00K derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $167.00K derived: sum of 2 quarters · filed 2023-03-27 | $173.00K derived: sum of 3 quarters · filed 2023-03-27 | $198.00K 10-K · filed 2023-03-27 | |||
| 2021-09-30 | $77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $83.00K derived: sum of 2 quarters · filed 2022-11-08 | $108.00K 10-Q · filed 2022-11-08 | $124.00K derived: sum of 4 quarters · filed 2022-11-08 | |||
| 2021-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $31.00K 10-Q · filed 2022-08-09 | $47.00K derived: sum of 3 quarters · filed 2022-08-09 | $54.00K derived: sum of 4 quarters · filed 2022-08-09 | |||
| 2021-03-31 | $25.00K 10-Q · filed 2022-05-10 | $41.00K derived: sum of 2 quarters · filed 2022-05-10 | $48.00K derived: sum of 3 quarters · filed 2022-05-10 | $48.00K derived: sum of 4 quarters · filed 2022-05-10 | |||
| 2020-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $23.00K derived: sum of 2 quarters · filed 2022-03-23 | $23.00K derived: sum of 3 quarters · filed 2022-03-23 | $24.00K 10-K · filed 2022-03-23 | |||
| 2020-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $7.00K derived: sum of 2 quarters · filed 2021-11-12 | $8.00K 10-Q · filed 2021-11-12 | ||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $1.00K 10-Q · filed 2021-08-11 | |||||
| 2020-03-31 | $1.00K 10-Q · filed 2021-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |